AB
Insider
Albert Bourla
Chairman & CEOAlbert Bourla (Chairman & CEO) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Pfizer Inc. (PFE). Across 1 priced purchase filing, the average 21-session return was +4.8% from execution and +4.8% from disclosure (delay-adjusted; derived). The largest single filing was $1.0M of PFE (38,000 sh × $26.34, as filed), executed Aug 12.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+4.8%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+4.8%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.0M
shares × price, as filed
Last traded
Aug 12
Filed Aug 12
Median ADV $1.0B across their filed names
Open performance→Volume by month
Buys $1.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
PFE
Pfizer Inc.
PFE · 1 buy · 0 sells
1 filing
Recent filings
PFEPURCHASE
Pfizer Inc.
View filing →
$1.0M38,000 sh × $26.34
Exec Aug 12
Filed Aug 12 · 4:04 PM ET